摘要 |
The invention relates to methods to treat specified clinical disorders such as hyperglycemia, type 2 diabetes, arthritis and multiple sclerosis. The invention also provides methods to identify and characterize drugs, which are characterized in part by eliciting a variable biologic or therapeutic effect on a biomolecule at one time and relative normalization of the biomolecule at another time point. Compounds include 17a-ethynylandrost-5-ene-3ß,7ß, 17ß-triol or androst-5-ene-3ß,4ß, 16a, 17ß-tetrol, which can be used as reference standards to facilitate assessing and characterizing such candidate drugs. |
申请人 |
HOLLIS-EDEN PHARMACEUTICALS, INC.;FRINCKE, JAMES, M.;READING, CHRISTOPHER, L. |
发明人 |
FRINCKE, JAMES, M.;READING, CHRISTOPHER, L. |